Minimal hepatic encephalopathy is associated to alterations in eye movements.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
07 10 2022
Historique:
received: 27 04 2022
accepted: 23 09 2022
entrez: 7 10 2022
pubmed: 8 10 2022
medline: 12 10 2022
Statut: epublish

Résumé

Minimal hepatic encephalopathy (MHE) is diagnosed using PHES battery, but other tests are more sensitive, and a simple tool for early MHE detection is required. Assessment of saccadic eye movements is useful for early detection of cognitive alterations in different pathologies. We characterized the alterations in saccadic eye movements in MHE patients, its relationship with cognitive alterations and its utility for MHE diagnosis. One-hundred and eighteen cirrhotic patients (86 without and 32 with MHE) and 35 controls performed PHES and Stroop test and an eye movements test battery by OSCANN system: visual saccades, antisaccades, memory-guided saccades, fixation test and smooth pursuit. We analyzed 177 parameters of eye movements, assessed their diagnostic capacity for MHE, and correlated with cognitive alterations. MHE patients showed alterations in 56 of the 177 variables of eye movements compared to NMHE patients. MHE patients showed longer latencies and worse performance in most eye movements tests, which correlated with mental processing speed and attention impairments. The best correlations found were for antisaccades and memory-guided saccades, and some parameters in these tests could be useful for discriminating MHE and NMHE patients. Eye movements analysis could be a new, rapid, reliable, objective, and reproducible tool for early diagnose MHE.

Identifiants

pubmed: 36207472
doi: 10.1038/s41598-022-21230-3
pii: 10.1038/s41598-022-21230-3
pmc: PMC9547018
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

16837

Informations de copyright

© 2022. The Author(s).

Références

Liver Int. 2013 Nov;33(10):1478-89
pubmed: 23714168
Metab Brain Dis. 2004 Dec;19(3-4):253-67
pubmed: 15554421
Hepatology. 2009 Oct;50(4):1175-83
pubmed: 19670416
Aliment Pharmacol Ther. 2007 Feb;25 Suppl 1:3-9
pubmed: 17295846
Metab Brain Dis. 2010 Sep;25(3):285-95
pubmed: 20852922
Sci Rep. 2018 Jun 25;8(1):9664
pubmed: 29941971
Liver Int. 2017 Jul;37(7):1013-1022
pubmed: 27988985
Clin Gastroenterol Hepatol. 2015 Nov;13(12):2048-61
pubmed: 26164219
Acta Neurol Scand. 2010 Jul;122(1):27-35
pubmed: 20003084
Sci Rep. 2019 Apr 29;9(1):6580
pubmed: 31036843
Sensors (Basel). 2018 Feb 09;18(2):
pubmed: 29425134
PLoS One. 2018 Nov 28;13(11):e0207589
pubmed: 30485332
Mult Scler J Exp Transl Clin. 2018 Apr 17;4(2):2055217318771781
pubmed: 29707228
World J Gastroenterol. 2014 Sep 7;20(33):11815-25
pubmed: 25206287
Aging Clin Exp Res. 2019 Nov;31(11):1591-1600
pubmed: 30659514
SAGE Open Med. 2019 Feb 28;7:2050312119832090
pubmed: 30834114
Am J Gastroenterol. 2001 Sep;96(9):2718-23
pubmed: 11569701
PLoS One. 2017 Oct 12;12(10):e0186463
pubmed: 29023586
Brain Res. 2012 Mar 22;1445:62-72
pubmed: 22325099
PLoS One. 2017 Feb 1;12(2):e0171211
pubmed: 28146589
Hepatology. 2013 Sep;58(3):1122-32
pubmed: 23389962
World J Gastroenterol. 2018 Dec 28;24(48):5446-5453
pubmed: 30622374
Metab Brain Dis. 2001 Jun;16(1-2):13-9
pubmed: 11726083
Hepatology. 2014 Aug;60(2):715-35
pubmed: 25042402
Brain. 2006 Mar;129(Pt 3):564-83
pubmed: 16399806
Front Hum Neurosci. 2017 Nov 27;11:563
pubmed: 29230169
Am J Gastroenterol. 2011 Mar;106(3):476-82
pubmed: 20978484
Metab Brain Dis. 2015 Jun;30(3):821-8
pubmed: 25586511
Exp Brain Res. 2011 Feb;208(3):385-97
pubmed: 21107543
J Hepatol. 2001 May;34(5):768-73
pubmed: 11434627
Neurosci Res. 2016 Oct;111:1-12
pubmed: 27153746
J Alzheimers Dis. 2015;44(1):1-12
pubmed: 25182738
Neurology. 2013 Oct 1;81(14):1235-43
pubmed: 23986300
Neuron. 2009 Sep 10;63(5):592-9
pubmed: 19755103
Nat Rev Neurosci. 2013 Dec;14(12):851-8
pubmed: 24149188
Neuroimage. 2012 Jul 16;61(4):1165-75
pubmed: 22465844
Metab Brain Dis. 2019 Feb;34(1):289-295
pubmed: 30506333
Hepatology. 2012 Feb;55(2):530-9
pubmed: 21953369
Hepatology. 2002 Mar;35(3):716-21
pubmed: 11870389
Hepatology. 2005 Oct;42(4):772-81
pubmed: 16175619

Auteurs

Franc Casanova-Ferrer (F)

Fundación de Investigación Hospital Clínico Universitario de Valencia-INCLIVA, 46010, Valencia, Spain.

Cecilia E García-Cena (CE)

Centre for Automation and Robotics, Universidad Politecnica de Madrid, Madrid, Spain.

Juan-Jose Gallego (JJ)

Fundación de Investigación Hospital Clínico Universitario de Valencia-INCLIVA, 46010, Valencia, Spain.

Alessandra Fiorillo (A)

Fundación de Investigación Hospital Clínico Universitario de Valencia-INCLIVA, 46010, Valencia, Spain.

Amparo Urios (A)

Fundación de Investigación Hospital Clínico Universitario de Valencia-INCLIVA, 46010, Valencia, Spain.

Alberto Calvo-Córdoba (A)

Centre for Automation and Robotics, Universidad Politecnica de Madrid, Madrid, Spain.

Maria-Pilar Ballester (MP)

Fundación de Investigación Hospital Clínico Universitario de Valencia-INCLIVA, 46010, Valencia, Spain.
Servicio de Medicina Digestiva, Hospital Clínico Universitario de Valencia, 46010, Valencia, Spain.

María Pilar Ríos (MP)

Servicio de Medicina Digestiva, Hospital Arnau de Vilanova, 46015, Valencia, Spain.

Lucía Durbán (L)

Servicio de Medicina Digestiva, Hospital Arnau de Vilanova, 46015, Valencia, Spain.

Marta R Hidalgo (MR)

Bioinformatics and Biostatistics Unit, Centro Investigación Príncipe Felipe, 46012, Valencia, Spain.

Francisco García (F)

Bioinformatics and Biostatistics Unit, Centro Investigación Príncipe Felipe, 46012, Valencia, Spain.

Vicente Felipo (V)

Laboratory of Neurobiology, Centro Investigación Príncipe Felipe, 46012, Valencia, Spain.

Carmina Montoliu (C)

Fundación de Investigación Hospital Clínico Universitario de Valencia-INCLIVA, 46010, Valencia, Spain. carmina.montoliu@uv.es.
Department of Pathology, Faculty of Medicine, University of Valencia/INCLIVA-Health Research Institute, Avda. Blasco Ibañez, 17, 46010, Valencia, Spain. carmina.montoliu@uv.es.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH